Intrauterine Devices Market PPT: Demand, Trends and Business Opportunities 2023-28

1
Global Intrauterine Devices (IUD) Market Research
and Forecast Report 2023-2028

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Intrauterine Devices (IUD) Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2023-2028," the global intrauterine
  devices market size reached US 4.3 Billion in
  2022.
• Intrauterine devices (IUDs) are small, T-shaped
  contraceptive devices that are inserted into the
  uterus by healthcare professionals to provide
  long-term birth control. They are categorized
  into two main types hormonal, which release a
  small amount of progestin hormone into the
  uterus, and copper, which release copper ions to
  prevent fertilization. The key characteristics of
  IUDs include long-term protection, offering
  several years of contraception, ranging from 3 to
  10 years depending on the type, and
  reversibility, as they can be removed at any
  time, allowing for fertility resumption. IUDs
  also require minimal maintenance once inserted,
  with regular check-ups ensuring that the device
  remains in place. The features that make IUDs
  popular include their effectiveness, with a
  success rate of over 99, making them one of the
  most reliable contraceptive methods available.
  Depending on personal needs and preferences,
  users have the flexibility to choose between
  hormonal and copper IUDs. Additionally, IUDs are
  generally considered safe, with serious
  complications being rare, although there may be
  some initial discomfort during insertion. The
  combination of effectiveness, long-term
  protection, reversibility, minimal maintenance,
  customization options, and safety establishes
  IUDs as an attractive and responsible choice for
  those seeking long-term birth control without
  permanent alteration to fertility.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/intrauterine-devices-ma
  rket/requestsample

4
Report Description

• Global Intrauterine Devices (IUD) Market Trends
• The increasing focus on family planning and the
  need for effective, long-term contraceptive
  methods represent one of the primary drivers for
  the growth of the intrauterine devices (IUDs)
  market. Moreover, intrauterine devices, medical
  instruments inserted into the uterus to prevent
  pregnancy, are instrumental in providing reliable
  contraception, enhancing the convenience of
  reproductive health management. In addition to
  this, the versatile application of IUDs in
  diverse demographic groups, catering to various
  lifestyle and medical needs, is acting as a
  catalyst for the market growth. Besides this, the
  rising demand for non-invasive contraceptive
  methods and the preference for options that
  provide long-term efficacy without daily
  attention are contributing to the market growth.
  Additionally, significant advancements in medical
  technology, such as the development of
  hormone-releasing IUDs and product variants with
  increased biocompatibility, are facilitating
  personalized health care and enhancing user
  comfort, thereby supporting the market growth.
  Alongside this, the increasing integration of
  patient-centric designs and safety protocols in
  IUDs, targeted at maximizing efficacy and
  minimizing potential side effects, is
  significantly driving the market growth.
  Furthermore, collaborations with healthcare
  professionals to develop IUDs that meet specific
  health requirements are fostering market growth.
  Other factors, such as increasing investments in
  sexual and reproductive health education,
  tailored marketing showcasing the advantages of
  intrauterine devices, and the growing importance
  of accessible and sustainable birth control
  solutions, are creating a positive outlook for
  the intrauterine devices market across the globe.
• Looking forward, IMARC Group expects the market
  to reach US 5.7 Billion by 2028, expanding at a
  growth rate (CAGR) of 4.75 during 2023-2028.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/intrauterine-devices-ma
  rket

5
Report Segmentation

• Breakup by Product
• Hormonal Intrauterine Device
• Copper Intrauterine Device
•  
• Breakup by End-Use
• Hospitals
• Gynaecology Clinics
• Community Healthcare
• Others
• Breakup by Region
• Europe
• North America
• Asia Pacific
• Middle East and Africa
• Latin America

6
Competitive Landscape with Key Players

• Actavis
• Bayer
• Teva Pharmaceuticals
• Allergan
• ANI Pharmaceuticals
• Eurogine
• OCON Medical
• Pregna
• SMB Corporation
• HLL Lifecare
• HRA Pharma
• Besins HealthCare

7
Key Questions Answered in the Report
8
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Intrauterine Devices
  (IUD) Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Breakup by Product
•   5.5    Market Breakup by End-Use
•   5.6    Market Breakup by Region
•   5.7    Market Forecast
•   5.8    SWOT Analysis
•   5.8.1    Overview
•   5.8.2    Strengths
•   5.8.3    Weaknesses
•   5.8.4    Opportunities
•   5.8.5    Threats  5.9    Value Chain
  Analysis
•   5.9.1    Overview
•   5.9.2    Research and Development
•   5.9.3    Raw Material Procurement       

9
Table of Contents

•   5.9.4    Manufacturing
•   5.9.5    Marketing
•   5.9.6    Distribution
•   5.9.7    End-Use
•   5.10    Porters Five Forces Analysis
•   5.10.1    Overview
•   5.10.2    Bargaining Power of Buyers
•   5.10.3    Bargaining Power of Suppliers
•   5.10.4    Degree of Competition
•   5.10.5    Threat of New Entrants
•   5.10.6    Threat of Substitutes
• 6  Market Breakup by Product
• 6.1 Hormonal Intrauterine Device
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Copper Intrauterine Device
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 7  Market Breakup by End-Use

10
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

11
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com